Premium Information is available for this item - Upgrade for $1 a day

6505-01-051-4829

Usp Dexamethasone Tablets

6505010514829 010514829 52-0790-90 HEXADROL

INC: 31236 Dexamethasone Tablets

6505-01-051-4829 DEXAMETHASONE TABLETS,USP 6505010514829 010514829

Managed by United States
NSN Created on 2 Dec 1977
Data Last Changed
November 2023
NATO Update Count
9
NATO Data Quality
6505-01-051-4829 DEXAMETHASONE TABLETS,USP 6505010514829 010514829 1/1
NSN 6505-01-051-4829 (Generic Image) 1/1

6505-01-051-4829 Stock and Availability Marketplace 6505-01-051-4829

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-01-051-4829 RQST NE eBay
eBay Updated Every Day
6505-01-051-4829 RQST eBay
Amazon Updated Every Day
6505-01-051-4829 RQST NE Amazon

6505-01-051-4829 Related Documents Related Documents 6505-01-051-4829 5+ Documents (More...)

52-0790-90 HEXADROL Managed by United States NSN Created on 2 Dec 1977 Data Last Changed November 2023
RQST NE Updated Every Day 6505-01-051-4829 RQST Updated Every Day 6505-01-051-4829 RQST NE Related Documents
6505-01-051-4829 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051-4829
6505-01-047-0089Usp Dexamethasone Tablets6505010470089 010470089 NDC00054-8180-25 NDC00052-0791-90 HEXADROL
Usp Dexamethasone Tablets 6505010514829 your Account Upgrade 6505-01-051-4829Usp Dexamethasone
Tablets6505010514829 010514829 52-0790-90 HEXADROL NumberManufacturerStatusNDC00052-0792-95 04508 Tablets6505004005022
Account Upgrade 6505-00-400-5022Usp Dexamethasone Tablets6505004005022 004005022 NDC00052-0792-95 HEXADROL
Usp Dexamethasone Tablets 6505010514829 your Account Upgrade 6505-01-051-4829Usp Dexamethasone
Tablets6505010514829 010514829 52-0790-90 HEXADROL NDC00052-0792-95HEXADROL NumberManufacturerStatusNDC00052
Account Upgrade 6505-01-004-9216Usp Dexamethasone Tablets6505010049216 010049216 NDC00052-0798-91 HEXADROL
your Account Upgrade 6505-01-051-4829Usp Dexamethasone Tablets6505010514829 010514829 52-0790-90 HEXADROL
Tablets6505004005022 004005022 NDC00052-0792-95 HEXADROL NumberManufacturerStatusNDC00052-0792-95 04508
051-4828 Usp Dexamethasone Tablets 6505010514828 Tablets6505004005022 004005022 NDC00052-0792-95 HEXADROL
Tablets 6505010514828 Tablets6505004005022 004005022 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051-4829
Usp Dexamethasone Tablets 6505010514829 Metallic Tube 4710144809119144809119,BA-1/2 4710144809119144809119

6505-01-051-4829 Demil Restrictions 6505-01-051-4829

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: U | EDC: | ADPEC:

6505-01-051-4829 is a Usp Dexamethasone Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.

6505-01-051-4829 End Users End Users 6505-01-051-4829

NASA (G57V)
Effective Date:
1 Apr 1991

6505-01-051-4829 Manufacturers Approved Sources 6505-01-051-4829

6505-01-051-4829 Technical Data Datasheet 6505-01-051-4829

Characteristic
Specifications
Active Medicament Medicinal Strength [AKJA]
1.500 Milligrams Dexamethasone Active Ingredient
Primary Container Type [CQCT]
Strip
Primary Container Content Quantity [CRLK]
10.000 Tablets
Total Primary Container Quantity [CSCW]
10

6505-01-051-4829 Similar Items Similar Supply Items to 6505-01-051-4829

6505-01-051-4829 Freight Data Freight Information 6505-01-051-4829

6505-01-051-4829 has freight characteristics.. 6505-01-051-4829 has a variance between NMFC and UFC when transported by rail and the description should be consulted.